289 related articles for article (PubMed ID: 31642783)
41. Nanotechnology-based strategies for combating toxicity and resistance in melanoma therapy.
Brys AK; Gowda R; Loriaux DB; Robertson GP; Mosca PJ
Biotechnol Adv; 2016; 34(5):565-577. PubMed ID: 26826558
[TBL] [Abstract][Full Text] [Related]
42. Tumor Microenvironment-Specific Functional Nanomaterials for Biomedical Applications.
Zhao L; Liu H; Xing Y; Wang R; Cheng Z; Lv C; Lv Z; Yu F
J Biomed Nanotechnol; 2020 Sep; 16(9):1325-1358. PubMed ID: 33419489
[TBL] [Abstract][Full Text] [Related]
43. Application of Nanotechnology in the Diagnosis and Therapy of Hepatocellular Carcinoma.
Hou XY; Jiang G; Yang CS; Tang JQ; Wei ZP; Liu YQ
Recent Pat Anticancer Drug Discov; 2016; 11(3):322-31. PubMed ID: 26955964
[TBL] [Abstract][Full Text] [Related]
44. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
Bertalan F; László B; Attila V
Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
[TBL] [Abstract][Full Text] [Related]
45. Combinatorial prospects of nano-targeted chemoimmunotherapy.
Da Silva CG; Rueda F; Löwik CW; Ossendorp F; Cruz LJ
Biomaterials; 2016 Mar; 83():308-20. PubMed ID: 26796043
[TBL] [Abstract][Full Text] [Related]
46. Colorectal cancer therapy mediated by nanomedicines.
Zhang S; Zhang H; Song P; Wang D; Wang Y
Chem Commun (Camb); 2023 Apr; 59(30):4423-4435. PubMed ID: 36950975
[TBL] [Abstract][Full Text] [Related]
47. New therapeutic options for advanced non-resectable malignant melanoma.
Stadler S; Weina K; Gebhardt C; Utikal J
Adv Med Sci; 2015 Mar; 60(1):83-8. PubMed ID: 25596540
[TBL] [Abstract][Full Text] [Related]
48. A Review of Theranostics Applications and Toxicities of Carbon Nanomaterials.
Gupta N; Rai DB; Jangid AK; Kulhari H
Curr Drug Metab; 2019; 20(6):506-532. PubMed ID: 30251600
[TBL] [Abstract][Full Text] [Related]
49. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
Chen Y; Chen H; Shi J
Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
[TBL] [Abstract][Full Text] [Related]
50. Inorganic nanomedicines and their labeling for biological imaging.
Kim KM; Kang JH; Vinu A; Choy JH; Oh JM
Curr Top Med Chem; 2013; 13(4):488-503. PubMed ID: 23432011
[TBL] [Abstract][Full Text] [Related]
51. Functional magnetic hybrid nanomaterials for biomedical diagnosis and treatment.
Tian X; Zhang L; Yang M; Bai L; Dai Y; Yu Z; Pan Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jan; 10(1):. PubMed ID: 28471067
[TBL] [Abstract][Full Text] [Related]
52. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
53. Modulating Hypoxia via Nanomaterials Chemistry for Efficient Treatment of Solid Tumors.
Liu Y; Jiang Y; Zhang M; Tang Z; He M; Bu W
Acc Chem Res; 2018 Oct; 51(10):2502-2511. PubMed ID: 30234960
[TBL] [Abstract][Full Text] [Related]
54. Nanomedicine as a potent strategy in melanoma tumor microenvironment.
Pautu V; Leonetti D; Lepeltier E; Clere N; Passirani C
Pharmacol Res; 2017 Dec; 126():31-53. PubMed ID: 28223185
[TBL] [Abstract][Full Text] [Related]
55. New Perspectives in Glioblastoma: Nanoparticles-based Approaches.
Luciano R; Battafarano G; Saracino R; Rossi M; Perrotta A; Manco M; Muraca M; Del Fattore A
Curr Cancer Drug Targets; 2017; 17(3):203-220. PubMed ID: 27528362
[TBL] [Abstract][Full Text] [Related]
56. A comprehensive review on novel targeted therapy methods and nanotechnology-based gene delivery systems in melanoma.
Rahimi A; Esmaeili Y; Dana N; Dabiri A; Rahimmanesh I; Jandaghian S; Vaseghi G; Shariati L; Zarrabi A; Haghjooy Javanmard S; Cordani M
Eur J Pharm Sci; 2023 Aug; 187():106476. PubMed ID: 37236377
[TBL] [Abstract][Full Text] [Related]
57. Hybrid Nanomaterials for Cancer Immunotherapy.
Li J; Lu W; Yang Y; Xiang R; Ling Y; Yu C; Zhou Y
Adv Sci (Weinh); 2023 Feb; 10(6):e2204932. PubMed ID: 36567305
[TBL] [Abstract][Full Text] [Related]
58. Research progress on hydrogel-based drug therapy in melanoma immunotherapy.
He W; Zhang Y; Qu Y; Liu M; Li G; Pan L; Xu X; Shi G; Hao Q; Liu F; Gao Y
BMB Rep; 2024 Feb; 57(2):71-78. PubMed ID: 38053295
[TBL] [Abstract][Full Text] [Related]
59. How are we applying nanogel composites in biomedicine?
Kar M; Molina M; Calderón M
Nanomedicine (Lond); 2017 Jul; 12(14):1627-1630. PubMed ID: 28635377
[No Abstract] [Full Text] [Related]
60. Photodynamic Therapy in Melanoma - Where do we Stand?
Baldea I; Giurgiu L; Teacoe ID; Olteanu DE; Olteanu FC; Clichici S; Filip GA
Curr Med Chem; 2018; 25(40):5540-5563. PubMed ID: 29278205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
